Cardiovascular

Cardiovascular
Cardiovascular disease
including
heart disease
andstroke
is a major global health concern and the leading cause of death and disability worldwide1
Mode of Action of Idarucizumab
(Praxbind®)
Document ID: MPR-PH-100003
01/06/2018
Author: Boehringer Ingelheim
Dabigatran inhibits the formation of blood clots by specifically binding to thrombin
123,000
Views
100k 340
Production date: May 2019